| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/06/2006 | CA2559312A1 Use of paliperidone for the treatment of a mental disorder in a psychiatric patient with reduced hepatic function |
| 12/05/2006 | USRE39420 1,2-Diphenylpyrrole derivatives, their preparation and their therapeutic uses |
| 12/05/2006 | USRE39419 Estrogen agonist/antagonist metabolites |
| 12/05/2006 | US7145039 Transfection reagents |
| 12/05/2006 | US7145037 Adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities, and process for preparing them |
| 12/05/2006 | US7145036 Highly pure (R,R)-formoterol L-tartrate composition obtained by crystallizing a first polymorph of (R,R)-formoterol L-tartrate from aqueous isopropyl alcohol |
| 12/05/2006 | US7145032 Treating neuronal injury and for life-extension |
| 12/05/2006 | US7145025 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 12/05/2006 | US7145020 Materials and methods for treating coagulation disorders |
| 12/05/2006 | US7145015 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain that latter as well as their use for the production of pharmaceutical agents |
| 12/05/2006 | US7145012 Cannabinoid receptor ligands and uses thereof |
| 12/05/2006 | US7145009 Pirazino(aza)indole derivatives |
| 12/05/2006 | US7145008 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 12/05/2006 | US7145006 PNA monomer and precursor |
| 12/05/2006 | US7145005 making the crystalline citrate salt thereof; drug useful as histamine H3 receptor modulator |
| 12/05/2006 | US7145002 Antibiotic product for therapy of infections |
| 12/05/2006 | US7144997 Vertebrate embryonic patterning-inducing proteins, compositions and uses related therto |
| 12/05/2006 | US7144992 Synergistic antimicrobial compositions and methods for reducing biofilm formation |
| 12/05/2006 | US7144922 By administering a glycol derivative, specifically diethylene glycol dibenzoate controlling replication of HIV by exposing an infected cell to said glycol derivative |
| 12/05/2006 | US7144920 asymmetrically-substituted xylylenediamines, e.g., N-(3-aminopropyl)-xylylenediamine; cancer, mucositis, asthma, inflammation, autoimmune disease, psoriasis, restentosis, rheumatoid arthritis, scleroderma, lupus, diabetes, tissue transplantation, osteoporosis, hyperparathyroidism, peptic ulcers, glaucoma |
| 12/05/2006 | US7144919 Polyoxyethylene-polyoxypropylene vitamin E and process for preparation thereof |
| 12/05/2006 | US7144918 Enzyme inhibitors; anticancer agents |
| 12/05/2006 | US7144917 For therapy and prophylaxis of cancer, angiogenesis, arthritis, connective tissue disease, cardiovascular disease, inflammation or autoimmune disease in a mammal |
| 12/05/2006 | US7144916 Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 12/05/2006 | US7144915 Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) |
| 12/05/2006 | US7144914 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias |
| 12/05/2006 | US7144913 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists |
| 12/05/2006 | US7144912 drugs such as (4-methoxy-5-(1H-indol-2yl-methylene)-2,2'-bi-1H-pyrrole) used as anticarcinogenic or antitumor agents |
| 12/05/2006 | US7144911 Anti-inflammatory medicaments |
| 12/05/2006 | US7144910 hydrolase enzyme antagonists such as N-{(6S,9R,11R)-2-[5-4-fluoroophenyl)-1-methyl-1H-pyrazol-3-yl]-5,6,7,8,9,10-hexahydro-6,9-methanobenzo[a][8]annulen-11-yl}-N'-(2,2,2-trifiuoroethyl)sulfamide that inhibit processing of amyloid precursor protein, useful in treating or preventing Alzheimer's disease |
| 12/05/2006 | US7144909 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands |
| 12/05/2006 | US7144908 Prophylaxis, therapy of respiratory system disorders |
| 12/05/2006 | US7144907 mitogen activated protein kinase inhibitors such as 6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methylbenzo[d]isoxazole-5-carboxylic acid (2-hydroxyethoxy)-amide, used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals |
| 12/05/2006 | US7144906 Heterocyclic compounds |
| 12/05/2006 | US7144905 Small molecules used to increase cell death |
| 12/05/2006 | US7144904 desferrithiocin analogs used as siderophores, for treatment of malaria in humans |
| 12/05/2006 | US7144903 CCR4 antagonists |
| 12/05/2006 | US7144902 Prodrugs of thrombin inhibitors |
| 12/05/2006 | US7144901 Oxadiazole derivatives and drugs containing these derivatives as the active ingredient |
| 12/05/2006 | US7144900 Pharmaceutical composition |
| 12/05/2006 | US7144899 Thrombin inhibitors |
| 12/05/2006 | US7144897 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases |
| 12/05/2006 | US7144896 heterocyclic imines such as 3-[6-(1-Methanesulfonyl-1-methyl-ethyl)-quinolin-8-yl]-N-[6-(4-methylsulfanyl-phenyl)-pyridin-3-yl]-benzamide, used as phosphodiesterases (pde4) inhibitors; side effect reduction |
| 12/05/2006 | US7144895 Benzene acetamide compounds useful as serine protease inhibitors |
| 12/05/2006 | US7144894 such as 2R-(N-1-t-butyloxycarbonylindol-5-ylmethyl-N-4-chlorophenylsulfonylamino)-4-methyl-pentanamide, used for treatment of Alzheimer's disease or Down's Syndrome |
| 12/05/2006 | US7144893 4-aryl quinols and analogs thereof as therapeutic agents |
| 12/05/2006 | US7144892 Treatment of cardiovascular and related pathologies |
| 12/05/2006 | US7144891 derivatives of acronycine such as cis-2-cinnamoyloxy-1-hydroxy-6-methoxy-3,3,14-trimethyl-1,2,3,14-tetrahydro-1H-benzo[b]pyrano[3,2-h]acridin-7-one, used as antitumor agents |
| 12/05/2006 | US7144890 Spiro-pentacyclic compounds |
| 12/05/2006 | US7144889 Triarylimidazoles |
| 12/05/2006 | US7144888 Vanilloid receptor ligands and their use in treatments |
| 12/05/2006 | US7144887 Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition |
| 12/05/2006 | US7144886 Dipeptidyl peptidase IV (DP-IV) inhibitors as anti-diabetic agents |
| 12/05/2006 | US7144885 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders |
| 12/05/2006 | US7144884 E.g., 4-[2-(4-Methylphenoxy)- or 4-[2-(4-Methylphenylsulfanyl)-phenyl]-3,6-dihydro-2H-pyridine or piperazine or the hydrochloride or oxalate; treating depression, anxiety disorder, and obsessive compulsive disorder. |
| 12/05/2006 | US7144883 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders |
| 12/05/2006 | US7144882 Central nervous system disorders; psychological disorders; inflammatory bowel disorders |
| 12/05/2006 | US7144881 2-(2-fluoro-phenyl)-cyclopropanecarboxylic acid[1-(2,3-dihydro-benzofuran-5-yl)-ethyl]-amide for example; for pain, migraine, neuropathic pain, bipolar disorders, convulsions, mania, epilepsy, anxiety, depression and neurodegenerative disorders |
| 12/05/2006 | US7144880 Compositions relating to novel compounds and targets thereof |
| 12/05/2006 | US7144879 Substituted metal-phthalocyanines, their preparation and the use thereof |
| 12/05/2006 | US7144878 Orally administering parasiticidal formulation comprising a mixture of an edible non-aqueous liquid, a thickening agent, agent effective against nematodes and obligate parasite flies, agent effective against nematodes, |
| 12/05/2006 | US7144877 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 12/05/2006 | US7144876 3,5-Disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 12/05/2006 | US7144875 Therapy for skin disorders; at least about 1 mu M (micromolar) lupeol |
| 12/05/2006 | US7144874 Aryl phosphate derivatives of d4T having activity against resistant HIV strains |
| 12/05/2006 | US7144873 Therapy for anticancer agents, blood disorders; dissolving in nonaqueous solvent |
| 12/05/2006 | US7144872 1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-carboxamides; adenosine receptors (A2A); for stimulating mammalian coronary vasodilatation for therapy and imaging the heart |
| 12/05/2006 | US7144871 Partial and full agonists of A1 adenosine receptors |
| 12/05/2006 | US7144870 Gene therapy; lyases; hyaluronidase; anticancer agents (retinoblastomas); kits |
| 12/05/2006 | US7144869 Drug delivery of polynucleotide to primate hepatocyte; high level of gene expression with transient increases in liver enzymes |
| 12/05/2006 | US7144868 7-(2'-C-methyl- beta -D-ribofuranosyl)-4-amino-5-(2'-trimethylsilylethyn-1-yl)-pyrrolo[2,3-d]pyrimidine; treating hepatitis C |
| 12/05/2006 | US7144867 Anticancer glycoside compounds |
| 12/05/2006 | US7144866 Parasiticides |
| 12/05/2006 | US7144865 Daily administering a mixture of zinc salt, cyclo-Hispro (soybean protein product), arachidonic acid; treating hypertension, high cholesterol, weight control; nutritional supplements, foods |
| 12/05/2006 | US7144845 Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 12/05/2006 | US7144733 Sensitizing cells to light; obtain cells, transform with vector containing preferential proteins, expose to retinal, illuminate, monitor cell response |
| 12/05/2006 | US7144710 Method for detecting inflammation and inflammatory conditions |
| 12/05/2006 | US7144696 Use of azetidinone compounds |
| 12/05/2006 | US7144590 Bioactive compositions derived from humulus lupulus |
| 12/05/2006 | US7144586 Compositions for preventing hormone induced adverse effects |
| 12/05/2006 | US7144585 Administered orally and capable of dissolving in lower portion of human digestive tract; fine powder incorporated into surfactant as dispersant or solubilizer; bioabsorbability |
| 12/05/2006 | US7144584 S(+) desmethylselegiline and its use to treat narcolepsy |
| 12/05/2006 | US7144583 Pesticidal composition |
| 12/05/2006 | US7144574 For therapy of multiple sclerosis |
| 12/05/2006 | US7144573 Acrylamide or N-vinyl-2-pyrrolidone copolymer with fatty acid-containing comonomer has end group comprising N-(2-Mercaptoethyl)-3,5-bis(4-benzoylbenzyloxy)benzamide; holds and positions albumin; passivation of biocompatible, tissue-contacting surfaces |
| 12/05/2006 | US7144570 comprising thaizolium, thiadiazolium or triazolium compounds or derivatives and additional active agents, emollients, humectants, dry-feel modifiers, waterproofing agents, insect repellants, antimicrobial preservatives, antioxidants, moisturizers |
| 12/05/2006 | CA2531834C Pharmaceutical compositions comprising pioglitazone and an insulin secretion enhancer |
| 12/05/2006 | CA2434386C Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 12/05/2006 | CA2414936C Thiophene retinoids |
| 12/05/2006 | CA2396458C Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 12/05/2006 | CA2387531C Purine derivatives |
| 12/05/2006 | CA2360313C Glucocorticoid receptor modulators |
| 12/05/2006 | CA2351730C Antiparasitic formulations containing avermectin 13-monosaccharide 5-oxime |
| 12/05/2006 | CA2338031C Biodegradable compositions for the controlled release of encapsulated substances |
| 12/05/2006 | CA2334711C Medicaments containing bisphosphonic acids and derivatives thereof which are provided for preventing and treating autoimmune diseases and allergies |
| 12/05/2006 | CA2326630C Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof |
| 12/05/2006 | CA2307121C Dofetilide polymorphs |
| 12/05/2006 | CA2296710C Improved multiparticulate tablet with quick disintegration |
| 12/05/2006 | CA2293713C Bispyrido-cycloheptane compounds useful for inhibition of farnesyl protein transferase |
| 12/05/2006 | CA2290624C Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs |